SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-24-000809
Filing Date
2024-04-05
Accepted
2024-04-05 10:14:05
Documents
1
Period of Report
2024-04-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form313531001mok_04052024.html 3  
1 OWNERSHIP DOCUMENT form313531001mok_04052024.xml 3 2303
  Complete submission text file 0000921895-24-000809.txt   3822
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address TRIDENT COURT, 1 OAKCROFT ROAD CHESSINGTON SURREY X0 KT9 1BD
Business Address
Mokhtar Firdauz (Reporting) CIK: 0001861217 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 24825061